STAT

APRIL 21, 2023

A medical student spoke emotionally about grappling with a diagnosis his classes told him little about. A young queer man took one test, got a different result on the next, and is now saving up the money needed for the most advanced diagnostics, which insurers rarely cover. A young woman tested positive, got little guidance from her doctor and found information on government sites that she interpreted as pushing abstinence.

363

363

PharmaVoice

APRIL 21, 2023

Peter Kirk’s marathon story of inspiration and perseverance.

264

264

STAT

APRIL 21, 2023

WASHINGTON — Amid a scramble to assemble a health care policy package in the Senate, a pair of key senators have significantly changed a proposal to cap insulin costs. The new legislation by Senate Diabetes Caucus co-chairs Sens. Jeanne Shaheen (D-N.H.) and Susan Collins (R-Maine) would cap insured patients’ insulin costs at $35 per month for at least one insulin of each type and dosage form, and require pharmacy benefit managers to pass through rebates they collect from insulin ma

Dosage 246

Dosage Packaging Diabetes 246

LifeProNow

APRIL 21, 2023

April 17, 2023 : “Bayer and its collaborator Regeneron will present new clinical data analyses for the investigational formulation aflibercept 8 mg at the Annual Meeting of The Association for Research in Vision and Ophthalmology (arvo.org) 2023 , in New Orleans, Louisiana, 23-27 April 2023. The data will highlight Bayer’s commitment to advancing the unmet need of extended treatment intervals in exudative retinal disease.

Diabetes 100

Diabetes 100

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

APRIL 21, 2023

As a third-year neurology resident at Mass General Brigham, I started my career at the height of the Covid-19 pandemic. Now Covid numbers may be down, but hospitals continue to overflow. On a 28-hour shift, I cared for more than 40 patients, 11 of whom were newly admitted to the hospital overnight. Stretched too thin, I skimmed through the patients’ medical charts and did a quick physical exam to make sure each person was stable.

Hospitals 246

Hospitals 246

The Pharmacist

APRIL 21, 2023

Shadow health secretary Wes Streeting has suggested that community pharmacy could play ‘a really big role’ in his vision of ‘neighbourhood’ healthcare. Speaking at an event hosted by healthcare thinktank The King’s Fund today, the Labour health secretary outlined how he thought primary care could be reformed to make it ‘fit for the future’. He […] The post Wes Streeting: ‘We could do a lot more with community pharmacy’ appeared first on The Pharmacist.

Community Pharmacies 103

Community Pharmacies 103

The Honest Apothecary

APRIL 21, 2023

Here I share some of the latest news, articles, editorials, or blog posts that fall generally under the theme of Pharma or healthcare. I might throw in a something off-topic from time to time which I found while wandering throughout the endless hallways and corridors of the internet. All article shared will be free to read and not locked behind an annoying paywall.

Pharmacy Technician 102

Pharmacy Technician Independent Pharmacies 102

Pharmaceutical Technology

APRIL 21, 2023

Moderna has signed an agreement with IBM to explore quantum computing and generative artificial intelligence (AI) for advancing and expediting its mRNA research. Moderna will gain access to IBM’s quantum computing systems, an emerging technology that harnesses quantum mechanics for solving complex problems that cannot be handled efficiently by classical computers.

98

98

BioPharma Dive

APRIL 21, 2023

The company has chosen to stop an extension portion of a key study after an external group of advisers reviewed the data available and concluded further treatment with the drug was unwarranted.

Immunity 96

Immunity Immunization 96

Pharmaceutical Technology

APRIL 21, 2023

Incyte has received marketing authorisation from the European Commission for Opzelura (ruxolitinib) cream 15mg/g to treat non-segmental vitiligo with facial involvement in adults and in adolescents aged 12 years and above. Opzelura is the first and only approved treatment across the European Union (EU) aimed at achieving repigmentation in the targeted patients.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

The Pharmacist

APRIL 21, 2023

Up to one in 20 new cases of diabetes could be linked to Covid infection, a large study has concluded. But people who were vaccinated against Covid did not have a higher risk of diabetes. An analysis of records from almost 630,000 people between the beginning of 2020 and the end of 2021 found a […] The post Up to 5% of new diabetes cases could be linked to Covid appeared first on The Pharmacist.

Diabetes 93

Diabetes Vaccines 93

Pharmaceutical Technology

APRIL 21, 2023

The US Food and Drug Administration (FDA) has pushed quizartinib’s Prescription Drug User Fee Act (PDUFA) date in newly diagnosed FLT3-ITD positive acute myeloid leukemia (AML) for the review of updates of Risk Evaluation and Mitigation Strategies (REMS) included in the application. The PDUFA date was extended by three months to July 24, based on an April 20 company announcement.

Chemotherapy 98

Chemotherapy 98

BioPharma Dive

APRIL 21, 2023

With cash running low and a search for a buyer underway, GenSight wants advice from regulators on the type of data that would support an approval.

102

102

The Pharmacist

APRIL 21, 2023

WHSmith has announced the expansion of its ‘one-stop-shops’ that combine stationery, books and gifts with pharmacy, health and beauty products. The first of these stores opened in 2019 at the retailer’s London Gatwick and London Heathrow airport locations, followed by another ‘one-stop-shop’ at London Euston station last year. WHSmith has announced that this summer, it […] The post WHSmith expanding its pharmacy one-stop-shops appeared first on The Pharmacist.

90

90

assurecare

APRIL 21, 2023

Earth day serves as an important reminder to implement eco-friendly solutions in our homes and businesses. In recent years, there has been a growing awareness of the need to adopt sustainable practices across all industries, including healthcare. As healthcare facilities are among the largest consumers of energy and water, they have a significant impact on the environment.

89

89

Pharma Times

APRIL 21, 2023

Companies will collaborate to boost novel treatments for individuals with geographic atrophy

114

114

European Pharmaceutical Review

APRIL 21, 2023

We have 27 years left to transform the EU into a climate-neutral continent in order to keep the ecological catastrophes that the climate crisis brings at a manageable level – to find solutions for every flight taken, every car driven and every medical treatment undergone in the EU. Other sectors are already on the way to reducing their emissions and have received much public and political attention.

Pharmaceutical Companies 83

Pharmaceutical Companies Pharmaceutical Companies Packaging 83

BioPharma Dive

APRIL 21, 2023

The stay suspends a Texas judge’s order that had invalidated the FDA’s approval of mifepristone, keeping it avaliable while a circuit court hears the case.

79

79

Pharma Times

APRIL 21, 2023

Study has been focusing on atogepant for the prevention of episodic migraine attacks

94

94

BioPharma Dive

APRIL 21, 2023

A decision by the Supreme Court could have far-reaching effects on the lucrative market for antibody drugs, spurring responses from many of the industry’s top companies.

73

73

The Guardian - Pharmaceutical Industry

APRIL 21, 2023

Exclusive: private company Sciensus has struggled to provide reliable service, Guardian investigation finds The care regulator has launched a review of serious and significant concerns raised by patients, clinicians and health groups about the safety and reliability of the services of Britain’s biggest medicines delivery business, the Guardian can reveal.

Diabetes 72

Diabetes 72

World Pharma News

APRIL 21, 2023

Multiple sclerosis (MS) is a devastating autoimmune disease that destroys the protective myelin covering around nerves, disrupting communication between the brain and body, and causing patients' ability to move and function to progressively decline. The Atlas of MS reported in 2020 that someone is diagnosed with MS every five minutes around the world, adding to about 2.8 million individuals that currently have to live with the disease.

Communication 65

Communication 65

Pharmaceutical Technology

APRIL 21, 2023

China’s National Medical Products Administration (NMPA) has cleared CARsgen Therapeutics’ CT041 investigational new drug (IND) for postoperative adjuvant therapy to treat CLDN18.2 positive pancreatic cancer (PC). CT041 is an autologous CAR T-cell product currently under development for use against the CLDN18.2 protein. It targets CLDN18.2 positive solid tumours by focusing primarily on gastric cancer/gastroesophageal junction cancer (GC/GEJ) and PC.

59

59

The Thyroid Pharmacist

APRIL 21, 2023

If you’re a little nerdy like me, you may have noticed that the abbreviation for my new book, Adrenal Transformation Protocol: A 4-Week Plan to Release Stress Symptoms and Go from Surviving to Thriving is ATP, and this is by design! ATP is short for adenosine triphosphate, which is our body’s main form of energy. It’s created in our mitochondria and fuels necessary everyday functions like protein synthesis, muscle contractions, and nerve impulse transmission.

Compounding 55

Compounding 55

Pharmaceutical Technology

APRIL 21, 2023

Biotechnology company Enveda Biosciences has raised $51m in equity financing in a Series B1 round to advance several drug candidates to clinical development. The Series B1 financing comes after the company raised equity and debt financing worth $68m in a Series B round in December 2022. It brings the total capital raised by the company to $175m. Led by new investor Kinnevik, the Series B1 financing round has also seen participation from another new investor, Henry R Kravis, co-founder of private

Compounding 59

Compounding 59

PharmaTech

APRIL 21, 2023

Rafael Antunes, vice-president of Business Development Europe at Aurisco, speaks about his company's recent efforts in the field of oligonucleotides, its partnership with Cytiva, and its broader sustainability efforts.

52

52

RX Note

APRIL 21, 2023

Introduction Occasionally, I consider compiling all the blog posts here into an offline eBook, so that learning can be done offline. Though there are many professional tools for creating an eBook, Microsoft Word essentially has many features that make creating eBooks easy. Design a Cover Some believes cover is the soul of the book, or rather it gives the potential customers the first impression.

Documentation 52

Documentation 52

Drug Patent Watch

APRIL 21, 2023

Annual Drug Patent Expirations for NEXLETOL Nexletol is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are six… The post New patent for Esperion Theraps drug NEXLETOL appeared first on DrugPatentWatch - Make Better Decisions.

52

52

RX Note

APRIL 21, 2023

Introduction Sleep is one of the most important but often neglected aspects of our daily lives. Many adults often sacrifice their sleep time when they feel busy, believing that limiting their sleep hours outweighs the costs. However, sleep is essential for brain function, physical health and emotional well-being. Recommended Hours The recommended amount of sleep varies depending on age.

Diabetes 52

Diabetes Immunity Immunization 52

Drug Patent Watch

APRIL 21, 2023

Annual Drug Patent Expirations for TAVNEOS Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Chemocentryx drug TAVNEOS appeared first on DrugPatentWatch - Make Better Decisions.

52

52

RX Note

APRIL 21, 2023

Introduction Giving medicines to infants and children can be challenging because they may refuse to take medications for many reasons, such as fear, taste, embarrassment or inconvenience. Choosing the Right Formulation When selecting medicines for children, it is important to consider factors such as Child's age Swallowing ability Ease of administration Accessibility of suitable formulations of the product Often, oral liquids are the preferred formulation for younger children as they are easier

Medical Compliance 52

Medical Compliance Dosage 52

Drug Patent Watch

APRIL 21, 2023

Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are seven… The post New patent for Esperion Theraps drug NEXLIZET appeared first on DrugPatentWatch - Make Better Decisions.

52

52

RX Note

APRIL 21, 2023

Introduction While dispensing cough syrup to a patient (I counselled him to take 10 ml 3 times a day), the patient questioned if it was equivalent to a tablespoon. Teaspoon and Tablespoon The conversion from teaspoon or tablespoon to millilitres is as below: 1 teaspoon = 5 ml 1 tablespoon = 15 ml However, a household silverware or tableware spoon are not uniformly sized, so they should not be used for measuring medication.

52

52

Drug Patent Watch

APRIL 21, 2023

Annual Drug Patent Expirations for VTAMA Vtama is a drug marketed by Dermavant Sci and is included in one NDA. It is available from one supplier. There are four patents… The post New patent for Dermavant Sci drug VTAMA appeared first on DrugPatentWatch - Make Better Decisions.

52

52

RX Note

APRIL 21, 2023

Introduction Today, we will be sharing a simple guide on how to reconstitute oral antibiotic suspension. After reconstitution, the suspension should normally be refrigerated between 2 and 8 ° C and can be kept for 5-7 days (up to 10 days for certain products). NOTE: It is important to check the product leaflet for specific storage and stability instructions post reconstitution as these may vary depending on the product.

Labelling 52

Labelling 52